HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, A. Articles by Steiner, D. F. Search for Related Content PubMed PubMed Citation Articles by Zhou, A. Articles by Steiner, D. F. Social Bookmarking                      What's this?

J Biol Chem, Vol. 273, Issue 18, 11107-11114, May 1, 1998

Regulatory Roles of the P Domain of the Subtilisin-like Prohormone Convertases

From the Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637

A unique feature of the eukaryotic subtilisin-like proprotein convertases (SPCs) is the presence of an additional highly conserved sequence of approximately 150 residues (P domain) located immediately downstream of the catalytic domain. To study the function of this region, which is required for the production of enzymatically active convertases, we have expressed and characterized various P domain-related mutants and chimeras in HEK293 cells and -TC1-6 cells. In a series of C-terminal truncations of PC3 (also known as PC1 or SPC3), PC3-Thr⁵⁹⁴ was identified as the shortest active form, thereby defining the functional C-terminal boundary of the P domain. Substitutions at Thr⁵⁹⁴ and nearby sites indicated that residues 592-594 are crucial for activity. Chimeric SPC proteins with interchanged P domains demonstrated dramatic changes in several properties. Compared with truncated wild-type PC3 (PC3-Asp⁶¹⁶), both PC3/PC2Pd and PC3/FurPd had elevated activity on several synthetic substrates as well as reduced calcium ion dependence, whereas Fur/PC2Pd was only slightly decreased in activity as compared with truncated furin (Fur-Glu⁵⁸³). Of the three active SPC chimeras tested, all had more alkaline pH optima. When PC3/PC2Pd was expressed in -TC1-6 cells, it accelerated the processing of proglucagon into glicentin and major proglucagon fragment and cleaved major proglucagon fragment to release GLP-1 and tGLP-1, similar to wild-type PC3. Thus, P domain exchanges generated fully active chimeric proteases in several instances but not in all (e.g. PC2/PC3Pd was inactive). The observed property changes indicate a role for the P domain in regulating the stability, calcium dependence, and pH dependence of the convertases.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. Waschkowitz, S. Rockstroh, and R. Daniel Isolation and Characterization of Metalloproteases with a Novel Domain Structure by Construction and Screening of Metagenomic Libraries Appl. Envir. Microbiol., April 15, 2009; 75(8): 2506 - 2516. [Abstract] [Full Text] [PDF]

				D. Szumska, G. Pieles, R. Essalmani, M. Bilski, D. Mesnard, K. Kaur, A. Franklyn, K. El Omari, J. Jefferis, J. Bentham, et al. VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5 Genes & Dev., June 1, 2008; 22(11): 1465 - 1477. [Abstract] [Full Text] [PDF]

				E. N. Hampton, M. W. Knuth, J. Li, J. L. Harris, S. A. Lesley, and G. Spraggon The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain PNAS, September 11, 2007; 104(37): 14604 - 14609. [Abstract] [Full Text] [PDF]

				L. Sun, D. L. Nuss, and N. Suzuki Synergism between a mycoreovirus and a hypovirus mediated by the papain-like protease p29 of the prototypic hypovirus CHV1-EP713 J. Gen. Virol., December 1, 2006; 87(12): 3703 - 3714. [Abstract] [Full Text] [PDF]

				M. M. Kacprzak, M. E. Than, L. Juliano, M. A. Juliano, W. Bode, and I. Lindberg Mutations of the PC2 Substrate Binding Pocket Alter Enzyme Specificity J. Biol. Chem., September 9, 2005; 280(36): 31850 - 31858. [Abstract] [Full Text] [PDF]

				X.-M. Sun, E. R. Eden, I. Tosi, C. K. Neuwirth, D. Wile, R. P. Naoumova, and A. K. Soutar Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia Hum. Mol. Genet., May 1, 2005; 14(9): 1161 - 1169. [Abstract] [Full Text] [PDF]

				S. Benjannet, D. Rhainds, R. Essalmani, J. Mayne, L. Wickham, W. Jin, M.-C. Asselin, J. Hamelin, M. Varret, D. Allard, et al. NARC-1/PCSK9 and Its Natural Mutants: ZYMOGEN CLEAVAGE AND EFFECTS ON THE LOW DENSITY LIPOPROTEIN (LDL) RECEPTOR AND LDL CHOLESTEROL J. Biol. Chem., November 19, 2004; 279(47): 48865 - 48875. [Abstract] [Full Text] [PDF]

				T. Nonaka, M. Fujihashi, A. Kita, K. Saeki, S. Ito, K. Horikoshi, and K. Miki The Crystal Structure of an Oxidatively Stable Subtilisin-like Alkaline Serine Protease, KP-43, with a C-terminal {beta}-Barrel Domain J. Biol. Chem., November 5, 2004; 279(45): 47344 - 47351. [Abstract] [Full Text] [PDF]

				G. C. Webb, A. Dey, J. Wang, J. Stein, M. Milewski, and D. F. Steiner Altered Proglucagon Processing in an {alpha}-Cell Line Derived from Prohormone Convertase 2 Null Mouse Islets J. Biol. Chem., July 23, 2004; 279(30): 31068 - 31075. [Abstract] [Full Text] [PDF]

				N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS Curbing activation: proprotein convertases in homeostasis and pathology FASEB J, July 1, 2003; 17(10): 1215 - 1227. [Abstract] [Full Text] [PDF]

				K. Ueda, G. M. Lipkind, A. Zhou, X. Zhu, A. Kuznetsov, L. Philipson, P. Gardner, C. Zhang, and D. F. Steiner Mutational analysis of predicted interactions between the catalytic and P domains of prohormone convertase 3 (PC3/PC1) PNAS, May 13, 2003; 100(10): 5622 - 5627. [Abstract] [Full Text] [PDF]

				A. Tsuji, T. Ikoma, E. Hashimoto, and Y. Matsuda Development of selectivity of {alpha}1-antitrypsin variant by mutagenesis in its reactive site loop against proprotein convertase. A crucial role of the P4 arginine in PACE4 inhibition Protein Eng. Des. Sel., February 1, 2002; 15(2): 123 - 130. [Abstract] [Full Text] [PDF]

				A. Bruzzaniti, R. Marx, and R. E. Mains Activation and Routing of Membrane-tethered Prohormone Convertases 1 and 2 J. Biol. Chem., August 27, 1999; 274(35): 24703 - 24713. [Abstract] [Full Text] [PDF]

				A. Zhou, G. Webb, X. Zhu, and D. F. Steiner Proteolytic Processing in the Secretory Pathway J. Biol. Chem., July 23, 1999; 274(30): 20745 - 20748. [Full Text] [PDF]

				C. Rovere, J. Luis, J.-C. Lissitzky, A. Basak, J. Marvaldi, M. Chretien, and N. G. Seidah The RGD Motif and the C-terminal Segment of Proprotein Convertase 1 Are Critical for Its Cellular Trafficking but Not for Its Intracellular Binding to Integrin alpha 5beta 1 J. Biol. Chem., April 30, 1999; 274(18): 12461 - 12467. [Abstract] [Full Text] [PDF]

				G. M. Lipkind, A. Zhou, and D. F. Steiner A model for the structure of the P domains in the subtilisin-like prohormone convertases PNAS, June 23, 1998; 95(13): 7310 - 7315. [Abstract] [Full Text] [PDF]

				L. Muller, A. Cameron, Y. Fortenberry, E. V. Apletalina, and I. Lindberg Processing and Sorting of the Prohormone Convertase 2 Propeptide J. Biol. Chem., December 8, 2000; 275(50): 39213 - 39222. [Abstract] [Full Text] [PDF]

				I. Jutras, N. G. Seidah, and T. L. Reudelhuber A Predicted alpha -Helix Mediates Targeting of the Proprotein Convertase PC1 to the Regulated Secretory Pathway J. Biol. Chem., December 15, 2000; 275(51): 40337 - 40343. [Abstract] [Full Text] [PDF]

				M. Fugere, P. C. Limperis, V. Beaulieu-Audy, F. Gagnon, P. Lavigne, K. Klarskov, R. Leduc, and R. Day Inhibitory Potency and Specificity of Subtilase-like Pro-protein Convertase (SPC) Prodomains J. Biol. Chem., March 1, 2002; 277(10): 7648 - 7656. [Abstract] [Full Text] [PDF]